Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Net Cash Flow (2020 - 2025)

Oncology Institute's Net Cash Flow history spans 6 years, with the latest figure at $5.9 million for Q4 2025.

  • For Q4 2025, Net Cash Flow rose 183.85% year-over-year to $5.9 million; the TTM value through Dec 2025 reached -$16.1 million, down 200.68%, while the annual FY2025 figure was -$16.1 million, 199.52% down from the prior year.
  • Net Cash Flow reached $5.9 million in Q4 2025 per TOI's latest filing, up from -$2.6 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $103.6 million in Q4 2021 to a low of -$47.4 million in Q4 2022.
  • Average Net Cash Flow over 5 years is $1.4 million, with a median of -$494000.0 recorded in 2023.
  • The largest YoY upside for Net Cash Flow was 3919.58% in 2021 against a maximum downside of 3379.02% in 2021.
  • A 5-year view of Net Cash Flow shows it stood at $103.6 million in 2021, then tumbled by 145.75% to -$47.4 million in 2022, then surged by 112.56% to $6.0 million in 2023, then tumbled by 65.04% to $2.1 million in 2024, then surged by 183.85% to $5.9 million in 2025.
  • Per Business Quant, the three most recent readings for TOI's Net Cash Flow are $5.9 million (Q4 2025), -$2.6 million (Q3 2025), and -$9.4 million (Q2 2025).